Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 27 |
| Active Pipeline (Recruiting Now) | 14 (10) |
| Completed vs Stopped Early | 1 / 4 (14.8%) |
| Median Closed Actual Enrollment | 6 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Xuanwu Hospital Capital Medical University | Beijing, Beijing Municipality | 10 |
Explore interactive annual charts and M&A subsidiary rollups in the Xuanwu Hospital, Beijing Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.